It is regulated and financed by the Canton of Bern. It is a comprehensive university offering a broad choice of courses and programmes in eight faculties and some 160 institutes. With around 15,000 students, the University of Bern is a medium-sized Swiss university.
The University of Bern has made a name for itself in fields as diverse as climate research, biomedicine and sustainable development research. The university has defined specific focuses of research as strategic and has established interdisciplinary centres of competence for these that pursue an interdisciplinary approach to research and teaching. The centres of competence also offer specialized masters programmes, for example the biomedical engineering programmes of the Artificial Organ (ARTORG) Center for Biomedical Engineering Research and the Public Management and Policy programme of the Center of Competence for Public Management (CCPM).
The Centre for Development and Environment (CDE) carries on the University of Bern’s long tradition in sustainable development research. The CDE also manages the NCCR North-South, Switzerland’s leading research programme in the fields of global change and sustainable development, focusing on its particular areas of expertise in integrated regional development andnatural resource management. The related field of international trade is the focus of the NCCR Trade Regulation, which is housed at the World Trade Institute (WTI) of the University of Bern. The WTI is a global leader among academic institutes focused on the legal, economic and political aspects of international trade regulation.
University of Bern research articles from Innovation Toronto
- Light in sight: a step towards a potential therapy for acquired blindness – May 11, 2015
- A possible alternative to antibiotics – November 5, 2014
- Batteryless cardiac pacemaker is based on automatic wristwatch
- Solar cells utilize thermal radiation
- Synthetic molecule could stop acute allergic reactions
- Particles Found to Travel Faster than Speed of Light
- Kinect could bring touch-free interface to operating theaters
First real-life study to provide data on the potential of powering medical implants with solar cells
The notion of using solar cells placed under the skin to continuously recharge implanted electronic medical devices is a viable one. Swiss researchers have done the math, and found that a 3.6 square centimeter solar cell is all that is needed to generate enough power during winter and summer to power a typical pacemaker.
The study is the first to provide real-life data about the potential of using solar cells to power devices such as pacemakers and deep brain stimulators. According to lead author Lukas Bereuter of Bern University Hospital and the University of Bern in Switzerland, wearing power-generating solar cells under the skin will one day save patients the discomfort of having to continuously undergo procedures to change the batteries of such life-saving devices. The findings are set out in Springer’s journal Annals of Biomedical Engineering.
Most electronic implants are currently battery powered, and their size is governed by the battery volume required for an extended lifespan. When the power in such batteries runs out, these must either be recharged or changed. In most cases this means that patients have to undergo implant replacement procedures, which is not only costly and stressful but also holds the risk of medical complications. Having to use primary batteries also influences the size of a device.
Various research groups have recently put forward prototypes of small electronic solar cells that can be carried under the skin and can be used to recharge medical devices. The solar cells convert the light from the sun that penetrates the skin surface into energy.
To investigate the real-life feasibility of such rechargeable energy generators, Bereuter and his colleagues developed specially designed solar measurement devices that can measure the output power being generated. The cells were only 3.6 square centimeters in size, making them small enough to be implanted if needed. For the test, each of the ten devices was covered by optical filters to simulate how properties of the skin would influence how well the sun penetrates the skin. These were worn on the arm of 32 volunteers in Switzerland for one week during summer, autumn and winter.
No matter what season, the tiny cells were always found to generate much more than the 5 to 10 microwatts of power that a typical cardiac pacemaker uses. The participant with the lowest power output still obtained 12 microwatts on average.
“The overall mean power obtained is enough to completely power for example a pacemaker or at least extend the lifespan of any other active implant,” notes Bereuter. “By using energy-harvesting devices such as solar cells to power an implant, device replacements may be avoided and the device size may be reduced dramatically.”
Bereuter believes that the results of this study can be scaled up and applied to any other mobile, solar powered application on humans. Aspects such as the catchment area of a solar cell, its efficiency and the thickness of a patient’s skin must be considered.
Learn more: The beating heart of solar energy
Synthetic biology is an emerging and rapidly evolving engineering discipline. Within the NCCR Molecular Systems Engineering, Bernese scientists have engineered a chemically switchable version of the light-driven proton pump proteorhodopsin – an essential tool for efficiently powering molecular factories and synthetic cells.
Synthetic biology is a highly interdisciplinary field, which combines biology, chemistry and physics with engineering. Its goal is to design molecular factories and synthetic cells with novel properties or functions for applications in healthcare, industry, or biological and medical research. Such artificial systems are in the nanometer scale and are built by combining and assembling existing, synthetic or engineered building blocks (e.g., proteins). Molecular systems have wide application ranges, e.g., for chemical compound synthesis, waste disposal, energy supply and medical diagnosis or treatment.
In this context, the NCCR Molecular Systems Engineering brings Swiss scientists from different disciplines together to stimulate innovation, and address existing and future challenges. The University of Bern is represented by the Fotiadis laboratory in the NCCR MSE.
Nanomachines for energy conversion
Energy-providing building blocks are essential to power molecular systems. Light-driven proton pumps such as the membrane protein proteorhodopsin represent excellent nanomachines for efficient energy conversion. Light energy, e.g., solar energy, is easily accessible and efficiently used by proteorhodopsin to establish proton gradients across membranes, which separate two different compartments. Such gradients can then be used to drive proton-driven building blocks of molecular systems, for example proton-driven transporters. Living cells commonly use proton gradients to power processes such as import and export of solutes and ions through transporters, and the synthesis of metabolites.
Eliminating the short-circuit
Using common methods for the assembly of proteorhodopsin, and membrane proteins in general, into containers such as liposomes or polymerosomes (i.e., spherical structures consisting of lipid or polymer membranes), symmetric integration in membranes is observed leading to short-circuit and failure in establishing a proton gradient. Therefore, members from the Fotiadis group, in particular Dr. Daniel Harder and Stephan Hirschi, together with colleagues from the NCCR MSE have implemented a chemical on-off switch into proteorhodopsin, thus extending its versatility and allowing the establishment of an asymmetric distribution of functional proteorhodopsin proteins in membranes by selectively deactivating one of the two possible orientations.
This engineered version of proteorhodopsin represents the first light-driven proton pump and energizing-building block that can be activated and deactivated chemically to meet the requirements of the molecular system. «Possible applications of this versatile energy-providing building block in specific molecular factories represent the light- and solar-powering of the production of molecules such as life’s universal energy currency ATP (adenosine triphosphate) and of the bioremediation of pollutants such as antibiotics in water resources», says Fotiadis. The study was published in the renowned scientific journal «Angewandte Chemie International Edition».